PAHC
Price
$26.57
Change
-$0.57 (-2.10%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
523.71M
22 days until earnings call
VTRS
Price
$8.98
Change
+$0.04 (+0.45%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
14.18B
2 days until earnings call
Interact to see
Advertisement

PAHC vs VTRS

Header iconPAHC vs VTRS Comparison
Open Charts PAHC vs VTRSBanner chart's image
Phibro Animal Health
Price$26.57
Change-$0.57 (-2.10%)
Volume$1.61K
Capitalization523.71M
Viatris
Price$8.98
Change+$0.04 (+0.45%)
Volume$60.17K
Capitalization14.18B
PAHC vs VTRS Comparison Chart in %
Loading...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PAHC vs. VTRS commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a Buy and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (PAHC: $26.59 vs. VTRS: $8.98)
Brand notoriety: PAHC and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PAHC: 77% vs. VTRS: 71%
Market capitalization -- PAHC: $523.71M vs. VTRS: $14.18B
PAHC [@Pharmaceuticals: Other] is valued at $523.71M. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 1 green FA rating(s).

  • PAHC’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 1 green, 4 red.
According to our system of comparison, VTRS is a better buy in the long-term than PAHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • PAHC’s TA Score: 6 bullish, 3 bearish.
  • VTRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than VTRS.

Price Growth

PAHC (@Pharmaceuticals: Other) experienced а -5.07% price change this week, while VTRS (@Pharmaceuticals: Other) price change was -2.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.52%. For the same industry, the average monthly price growth was +63.14%, and the average quarterly price growth was +85.02%.

Reported Earning Dates

PAHC is expected to report earnings on Nov 05, 2025.

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.52% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than PAHC($524M). VTRS has higher P/E ratio than PAHC: VTRS (238.80) vs PAHC (34.11). PAHC YTD gains are higher at: 30.530 vs. VTRS (-26.247). VTRS has higher annual earnings (EBITDA): 3.52B vs. PAHC (83.7M). VTRS has more cash in the bank: 1.18B vs. PAHC (92.5M). PAHC has less debt than VTRS: PAHC (513M) vs VTRS (18.4B). VTRS has higher revenues than PAHC: VTRS (15.4B) vs PAHC (982M).
PAHCVTRSPAHC / VTRS
Capitalization524M14.2B4%
EBITDA83.7M3.52B2%
Gain YTD30.530-26.247-116%
P/E Ratio34.11238.8014%
Revenue982M15.4B6%
Total Cash92.5M1.18B8%
Total Debt513M18.4B3%
FUNDAMENTALS RATINGS
PAHC vs VTRS: Fundamental Ratings
PAHC
VTRS
OUTLOOK RATING
1..100
5672
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4362
P/E GROWTH RATING
1..100
881
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (50) in the Pharmaceuticals Major industry is in the same range as VTRS (50) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

PAHC's Profit vs Risk Rating (75) in the Pharmaceuticals Major industry is in the same range as VTRS (100) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

PAHC's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as VTRS (100) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

PAHC's Price Growth Rating (43) in the Pharmaceuticals Major industry is in the same range as VTRS (62) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for PAHC (88) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew significantly faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCVTRS
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 14 days ago
70%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 6 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WFIOX57.09N/A
N/A
Allspring Index Admin
MSIWX15.51N/A
N/A
Morgan Stanley Inst EMkts Ldrs IR
LOAGX15.81N/A
N/A
Lord Abbett International Growth F3
IEMFX34.51N/A
N/A
T. Rowe Price Instl Emerging Mkts Eq
WMGAX26.24N/A
N/A
Macquarie Mid Cap Growth A

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+3.94%
PBH - PAHC
51%
Loosely correlated
+0.65%
AMRX - PAHC
47%
Loosely correlated
+1.73%
ZTS - PAHC
41%
Loosely correlated
+3.01%
ELAN - PAHC
40%
Loosely correlated
+2.03%
VTRS - PAHC
38%
Loosely correlated
+1.48%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+1.48%
ELAN - VTRS
50%
Loosely correlated
+2.03%
ZTS - VTRS
45%
Loosely correlated
+3.01%
AMRX - VTRS
45%
Loosely correlated
+1.73%
PBH - VTRS
41%
Loosely correlated
+0.65%
PAHC - VTRS
38%
Loosely correlated
+3.94%
More